vimarsana.com
Home
Live Updates
ASA Not Best Antiplatelet in Established CAD: Meta-Analysis
ASA Not Best Antiplatelet in Established CAD: Meta-Analysis
ASA Not Best Antiplatelet in Established CAD: Meta-Analysis
Clopidogrel or ticagrelor may be safer and more effective than traditional aspirin for secondary prevention, suggests evidence from seven randomized trials.
Related Keywords
Dallas ,
Texas ,
United States ,
University Of Texas ,
Italy ,
America ,
Felice Gragnano ,
Dharam Kumbhani ,
Eli Lilly ,
Coll Cardiol ,
University Of Texas Southwestern ,
Novo Nordisk ,
Astrazeneca ,
Journal Of The American College Cardiology ,
University Of Campania Luigi Vanvitelli ,
Campania Luigi Vanvitelli ,
American College ,
North America ,
Texas Southwestern ,
Cv ,
Ardiovascular ,
Acute Coronary Syndrome Acs ,
Cute Coronary Syndrome ,
Cs ,
Stroke ,
Erebrovascular Accident ,
Va Cerebrovascular Accident ,
Primary And Secondary Prevention Of Coronary Artery Disease ,
Rimary And Secondary Prevention Of Coronary Heart Disease ,
Rimary And Secondary Prevention Of Atherosclerotic Heart Disease ,
Rimary And Secondary Prevention Of Atherosclerotic Cardiovascular ,
A ,